Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
16
2024
Supreme Court Decision Overturns Chevron: Impact on Cannabis Industry Norris McLaughlin P.A.
Jul
16
2024
June 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Jul
16
2024
Navigating the Legal Boundaries of Telehealth Womble Bond Dickinson (US) LLP
Jul
16
2024
The Science of Drug Testing Womble Bond Dickinson (US) LLP
Jul
16
2024
Defense Contracting, Cybersecurity and COVID: Major Qui Tam Settlements from June 2024 Kohn, Kohn & Colapinto
Jul
16
2024
Second Circuit Remands ‘Whole Wheat Flour’ Cracker Label Lawsuit Keller and Heckman LLP
Jul
16
2024
Patenting Power Plays For AI Drug Discovery Foley & Lardner LLP
Jul
16
2024
Recent Federal Developments, July 2024 Bergeson & Campbell, P.C.
Jul
15
2024
Mintz IRA Update — IRA Litigation Update: Courts Begin to Address Legal Challenges to the Medicare Drug Price Negotiation Program Mintz
Jul
15
2024
Mintz IRA Update — The Consequences and Costs of Redesigning the Part D Program Mintz
Jul
15
2024
Mintz IRA Update — Biden Administration Proposes Allowing Agencies to 'March-In' to Control Rising Drug Prices Mintz
Jul
15
2024
Mintz IRA Update — Learning From Experience: Medicare Drug Price Negotiation Program Updates Mintz
Jul
15
2024
Mintz IRA Update — Opposition to the Use of March-In Rights to Lower Drug Prices Mintz
Jul
15
2024
Mintz IRA Update — The Growing Use of State Prescription Drug Affordability Boards Mintz
Jul
15
2024
USDA’s Biotechnology Regulator Issues Much-Anticipated RFI on Regulation of Modified Microbes ArentFox Schiff LLP
Jul
12
2024
FDA Releases Guidance for Final Rule Regulating Laboratory Developed Tests Greenberg Traurig, LLP
Jul
12
2024
Liquor Code Changes Pass Pennsylvania Legislature Norris McLaughlin P.A.
Jul
12
2024
DOJ Announces Agreement With Rite Aid to Settle Allegations of Violating the FCA and CSA in Relation to Opioid Dispensing ArentFox Schiff LLP
Jul
12
2024
Trending in Telehealth: July 2 – 8, 2024 McDermott Will & Emery
Jul
11
2024
Loper Bright and the 340B Statute McDermott Will & Emery
Jul
11
2024
Complying with “Made in USA” Standards, Now a Little Easier and a Little Tougher Keller and Heckman LLP
Jul
11
2024
Is Pleading “Generic” Enough to Plead Inducement? McDermott Will & Emery
Jul
10
2024
Growing Regulatory Focus on ‘Crossover Alcohol Products’ McDermott Will & Emery
Jul
10
2024
Five Observations from FDA’s Responses to Comments in the Final Rule on LDTs Mintz
Jul
10
2024
Important Update for New Jersey Alcohol Manufacturers: Changes to Brand Registration and Renewal Process Norris McLaughlin P.A.
Jul
10
2024
Court Vacates TSCA Section 4 Test Order, Grant’s Vinyl Institute’s Petition for Review Bergeson & Campbell, P.C.
Jul
10
2024
USDA’s Spring 2024 Unified Agenda Includes Rulemakings Concerning Biobased Products and Biotechnology Bergeson & Campbell, P.C.
Jul
10
2024
CODEX ALIMENTARIUS: Outcome of 54th Codex Committee on Food Additives (CCFA54) Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins